European best practice guidelines for the management of anaemia in patients with chronic renal failure - Foreword

被引:3
作者
Berthoux, F
机构
关键词
D O I
10.1093/ndt/14.suppl_5.1
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:1 / 50
页数:50
相关论文
共 571 条
[1]  
ABELS RI, 1992, SEMIN ONCOL, V19, P29
[2]   RENAL-FUNCTION DURING ERYTHROPOIETIN THERAPY FOR ANEMIA IN PREDIALYSIS CHRONIC-RENAL-FAILURE PATIENTS [J].
ABRAHAM, PA ;
OPSAHL, JA ;
RACHAEL, KM ;
ASINGER, R ;
HALSTENSON, CE .
AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 (02) :128-136
[3]  
ABUALFA A, 1997, J AM SOC NEPHROL, V8, pA225
[4]  
ADAMSON JW, 1989, Q J MED, V73, P1093
[5]   Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure [J].
Ahluwalia, N ;
Skikne, BS ;
Savin, V ;
Chonko, A .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (04) :532-541
[6]  
Ahsan N, 1996, ADV PERIT D, V12, P161
[7]  
Akcicek F, 1997, ADV PERIT D, V13, P109
[8]   Use of iv iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin [J].
Al-Hawas, F ;
Abdalla, AH ;
Popovich, W ;
Mousa, DH ;
Al-Sulaiman, MH ;
Al-Khader, AA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (12) :2801-2802
[9]   High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients [J].
Albitar, S ;
Genin, R ;
Fen-Chong, M ;
Serveaux, MO ;
Bourgeon, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (05) :1206-1210
[10]   SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF ERYTHROPOIETIN IMPROVES ITS EFFICIENCY FOR THE TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS [J].
ALBITAR, S ;
MEULDERS, Q ;
HAMMOUD, H ;
SOUTIF, C ;
BOUVIER, J ;
POLLINI, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 :40-43